Signify Health, Inc. (SGFY) Misses Q2, Guides Lower

Signify Health, Inc. (NYSE: SGFY) reported Q2 EPS of ($2.10), which may not compare to the analyst estimate of $0.13. Revenue for the quarter came in at $246.2 million versus the consensus estimate of $247.09 million.

GUIDANCE:

Signify Health, Inc. sees FY2022 revenue of $800-810 million, versus the consensus of $957.6 million.

For earnings history and earnings-related data on Signify Health, Inc. (SGFY) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c